user profile avatar

Aryan Roghani

1,105

Bold Points

1x

Finalist

1x

Winner

Bio

I'm an incoming sophomore at UT Austin with a major in Biomedical Engineering and minor in Entrepreneurship. Some of my hobbies include competitive chess, indoor and outdoor soccer, golf, jiu-jitsu, volunteer tutoring, and expanding my knowledge in business and biomedical sciences, particularly in neuro-engineering. My achievements include: 2023 & 2024 International Medicine & Disease Olympiad (IMDO) Gold Medalist; 2x Team USA Member. 2022 Harvard MIT Math Tournament (HMMT); Top 75 International Sweepstakes. 2x United States of America Biology Olympiad (USABO) Semifinalist. 2x American Invitational Mathematics Exam (AIME) Qualifier; 1x AIME with Distinction (Score: 130.5/150) Research Publications: 1. Treating Alzheimer's disease using nanoparticle-mediated drug delivery strategies/systems. Ageing research reviews, 97, 102291. https://doi.org/10.1016/j.arr.2024.102291 2. Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements. Ageing research reviews, 99, 102410. https://doi.org/10.1016/j.arr.2024.102410 3. Caring for Individuals with Alzheimer's Disease: A Spotlight on Hispanic Caregivers. Journal of Alzheimer's disease reports, 8(1), 877–902. https://doi.org/10.3233/ADR-240035 4. Role of diet and exercise in aging, Alzheimer's disease, and other chronic diseases. Ageing research reviews, 91, 102091. https://doi.org/10.1016/j.arr.2023.102091 5. Harnessing Artificial Intelligence for the detection and management of Colorectal Cancer Treatment. Cancer prevention research. https://doi.org/10.1158/1940-6207.CAPR-24-0178

Education

The University of Texas at Austin

Bachelor's degree program
2024 - 2028
  • Majors:
    • Biomedical/Medical Engineering
  • Minors:
    • Entrepreneurial and Small Business Operations

Frenship High School

High School
2020 - 2024

Miscellaneous

  • Desired degree level:

    Doctoral degree program (PhD, MD, JD, etc.)

  • Graduate schools of interest:

  • Transfer schools of interest:

  • Majors of interest:

    • Biomedical/Medical Engineering
    • Neurobiology and Neurosciences
    • Entrepreneurial and Small Business Operations
  • Planning to go to medical school
  • Career

    • Dream career field:

      Biotechnology

    • Dream career goals:

      Biotech Entrepreneur/Researcher

    • Bagger

      United Supermarkets
      2021 – 2021

    Sports

    Mixed Martial Arts

    Club
    2024 – Present1 year

    Golf

    Club
    2024 – Present1 year

    Soccer

    Varsity
    2020 – Present5 years

    Awards

    • Fall 2024 Intramural Men's A Champions

    Research

    • Environmental/Environmental Health Engineering

      Texas Tech University Maddox Engineering Research Center - Dr. Danny Reible — High School Research Intern
      2023 – 2025
    • Neurobiology and Neurosciences

      Texas Tech University Health Sciences Center - Dr. Hemachandra Reddy — Intern Scientific Writer/Researcher
      2023 – Present

    Public services

    • Volunteering

      HOSA — President
      2022 – 2024
    • Volunteering

      Frenship Tutoring — Founder/President
      2022 – 2024

    Future Interests

    Advocacy

    Volunteering

    Philanthropy

    Entrepreneurship

    Henry Respert Alzheimer's and Dementia Awareness Scholarship
    Imagine waking up one day and not recognizing your face in the mirror. You’ve forgotten the names of your loved ones, the places you’ve visited, and the memories you’ve made. The responsible culprit: Alzheimer’s Disease (AD). It was over dinner on a stormy November evening in junior year when my parents revealed to me that my bloodline had the genetic presence of APOE4, an allele regarded to increase one's chance of developing AD. At that moment, I felt shocked and scared, at first believing I was a victim of my “ancestors’ curse". Curious to investigate, I started searching for answers, eventually realizing that science controlled my destiny, not fate. Like Henry Respert, my family's journey with Alzheimer's revealed how dementia steals not just memories, but dignity. His story as a Detroit mentor mirrors my commitment to turning fear into action. Driven by both fear and hope, I sought an opportunity to contribute to the fight against AD. When I first joined Professor Hemachandra Reddy’s lab, I was excited but slightly intimidated. As a high schooler in a lab full of med students and postdocs, I didn’t know whether I would be welcomed. While I entered unsure of what to expect, I quickly realized that my peers never judged my age, but the ideas and work I brought forward. I found a second home in that research lab, but the research insights I gained were even more meaningful. Throughout the process, I learned how to apply software, such as EndNote for referencing, BioRender for creating detailed figures and tables, and PubMed for reading past literature. Professor Reddy also shared his experiences with confounding AbSynapTEX, LLC (a medical research company, particularly focused on AD), which I plan to implement as an undergraduate researcher. Eventually Professor Reddy allowed me to go one step further and lead my own project, resulting in a first-author publication on how damaged cholinergic receptors in the brain of AD patients could be systematically treated by nanoparticles engineered to bypass the blood-brain barrier, delivering drugs directly to affected neurons. After publishing five papers so far with Reddy's lab, I began envisioning a career for myself in the field. I wish to start my own medical technology business, focusing on treating neurodegenerative diseases and an endgame of reconnecting neuronal pathways. Now as Director of Research and Development for Longhorn Neurotech, I've built mentorship programs that give students the same transformative opportunities Dr. Reddy gave me. Last semester, my team trained over fifty undergraduates in EEG/EMG headset and prosthetics development, the same technology we're adapting to help Alzheimer's and ALS patients communicate with their loved ones again. By applying all my experiences gained from Reddy's lab and my time at UT Austin as a Biomedical Engineer and entrepreneur, I hope to be able to come up with medical devices capable of being implanted in AD patients, providing possible early detection and easier delivery. Ultimately, I plan on collaborating with similar biopharmaceutical companies, like BioGen, in developing the future of effective drug therapy. Because no matter how potent the medications might be in treating the disease, overcoming organic obstacles, such as breaching the Blood-Brain Barrier in Alzheimer's Disease, is essential for achieving a successful procedure and preventing harmful side effects in patients. Since my first day in the lab, I’ve grown more confident in myself and am growing into the scientist I dreamt of becoming. When I presented my research at the 2nd Healthy Aging and Dementia Research Symposium, my age was irrelevant, and my disability felt easier to handle. In that lab environment, my most significant discovery was shining within myself: I found a community dedicated to fighting neurological disorders, and the light to call myself a scientist. It's been 118 years since we discovered AD, and countless victims have been lost, including two of my grandparents. However, through years of further innovative research in college and beyond, I seek to forge new headlines: "Scientists have found a new easily administered drug capable of reversing the progression of Alzheimer's Disease."
    Aryan Roghani Student Profile | Bold.org